biotech · Pulmonary Arterial Hypertension · Pulmonary Arterial Hypertension (PAH) · IKT
Inhibikase Therapeutics
News and analysis for Inhibikase Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Wilmington, USA HQ
29 Employees
Public company Type
IKT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Wilmington, USA
- Employees
- 29
- Programs
- 4
- Drugs
- 5
- Patents
- 9
News & analysis
NovaPharmaNews articles mentioning Inhibikase Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Inhibikase Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.